$MVNC
Marvion Inc. Stock $mvnc

$mvnc Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000168316823003294 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$3.858M	$1.700M	$107.8K
YoY Change	291.15%	1477.15%
Cost Of Revenue	$12.63K	$1.402M	$37.78K
YoY Change	-98.47%	3611.27%
Gross Profit	$3.845M	$297.6K	$69.99K
YoY Change	2261.35%	325.18%
Gross Profit Margin	99.67%	17.51%	64.94%
Selling, General & Admin	$1.496M	$635.7K	$570.9K
YoY Change	59.61%	11.36%
% of Gross Profit	38.9%	213.63%	815.65%
Research & Development	$7.653M	$134.1K	$505.9K
YoY Change	7464.99%	-73.49%
% of Gross Profit	199.01%	45.07%	722.86%
Depreciation & Amortization	$12.43K	$12.56K	$12.38K
YoY Change	2.22%	1.45%
% of Gross Profit	0.32%	4.22%	17.69%
Operating Expenses	$1.496M	$635.7K	$1.077M
YoY Change	59.61%	-40.96%
Operating Profit	-$7.154M	-$517.3K	-$1.007M
YoY Change	652.16%	-48.62%
Interest Expense	-$227.6K	$0.00	-$21.91K
YoY Change	-6894.33%	-100.0%
% of Operating Profit
Other Income/Expense, Net	-$227.6K	$263.00	$0.00
YoY Change	-6902.96%
Pretax Income	-$7.382M	-$517.0K	-$1.030M
YoY Change	678.82%	-49.8%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.382M	-$517.0K	-$1.030M
YoY Change	681.98%	-49.8%	-21747.06%
Net Earnings / Revenue	-191.34%	-30.42%	-955.71%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$551.50
COMMON SHARES
Basic Shares Outstanding	4.554B shares	1.943B shares	1.868B shares
Diluted Shares Outstanding	3.097B shares	142.7B shares	140.3B shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$917.5K	$74.95K	$61.39K
YoY Change	39.52%	22.09%
Cash & Equivalents	$189.9K	$64.93K	$61.39K
Short-Term Investments	$727.6K	$10.03K	$86.14K
Other Short-Term Assets	$10.75K	$10.03K	$107.1K
YoY Change	-98.3%	-90.64%
Inventory	$0.00	$0.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$4.178M	$4.783M	$168.5K
YoY Change	-58.06%	2738.3%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$63.26K	$82.26K
YoY Change	-45.05%
Long-Term Investments
YoY Change
Other Assets	$199.0K	$176.3K
YoY Change
Total Long-Term Assets	$262.3K	$258.5K	$130.4K
YoY Change	127.85%	98.21%
TOTAL ASSETS
Total Short-Term Assets	$4.178M	$4.783M	$168.5K
Total Long-Term Assets	$262.3K	$258.5K	$130.4K
Total Assets	$4.441M	$5.041M	$298.9K
YoY Change	-55.93%	1586.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$11.47M	$5.933M	$3.024M
YoY Change	210.27%	96.16%
Deferred Revenue
YoY Change
Short-Term Debt	$160.0K	$60.00K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.34M	$7.555M	$3.451M
YoY Change	219.7%	118.91%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.34M	$7.555M	$3.451M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$13.34M	$7.555M	$3.451M
YoY Change	219.7%	118.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$34.10M	-$26.72M
YoY Change	88.09%
Common Stock	$455.4K	$194.3K
YoY Change	143.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$8.895M	-$2.513M	-$3.152M
YoY Change
Total Liabilities & Shareholders Equity	$4.441M	$5.041M	$298.9K
YoY Change	-55.93%	1586.46%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$7.382M	-$517.0K	-$1.030M
YoY Change	681.98%	-49.8%	-21747.06%
Depreciation, Depletion And Amortization	$12.43K	$12.56K	$12.38K
YoY Change	2.22%	1.45%
Cash From Operating Activities	-$121.0K	-$112.4K	-$103.7K
YoY Change	32.54%	8.42%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$1.890K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$1.890K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	244.9K	$77.31K	138.8K
YoY Change	342.32%	-44.3%
NET CHANGE
Cash From Operating Activities	-121.0K	-$112.4K	-103.7K
Cash From Investing Activities	0.000	$0.00	-1.890K
Cash From Financing Activities	244.9K	$77.31K	138.8K
Net Change In Cash	123.9K	-$34.35K	33.22K
YoY Change	-445.11%	-203.4%
FREE CASH FLOW
Cash From Operating Activities	-$121.0K	-$112.4K	-$103.7K
Capital Expenditures	$0.00	$0.00	-$1.890K
Free Cash Flow	-$121.0K	-$112.4K	-$101.8K
YoY Change	32.54%	10.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001439264
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	000-53612
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	BONANZA GOLDFIELDS CORP.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-2723015
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	21st Floor
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Centennial Tower
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	3 Temasek Avenue
CY2023Q1	dei	Entity Address Country EntityAddressCountry	SG
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	039190
CY2023Q1	dei	City Area Code CityAreaCode	65
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	6829 7029
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4553837889	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64925	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99274	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	10027	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10203	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	0	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1387500	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4707875	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3057342	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	4782827	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4554319	usd
CY2023Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	176250	usd
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	176250	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	82255	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	94205	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	258505	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	270455	usd
CY2023Q1	us-gaap	Assets Assets	5041332	usd
CY2022Q4	us-gaap	Assets Assets	4824774	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	138890	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	105381	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5793839	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	5172537	usd
CY2023Q1	BONZ	Amounts Due To Related Parties Current AmountsDueToRelatedPartiesCurrent	1560643	usd
CY2022Q4	BONZ	Amounts Due To Related Parties Current AmountsDueToRelatedPartiesCurrent	1544729	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	60000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	1263	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1272	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	7554635	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6823919	usd
CY2023Q1	us-gaap	Liabilities Liabilities	7554635	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6823919	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2023Q1	BONZ	Preferred Stock Shares Undesignated PreferredStockSharesUndesignated	18999999	shares
CY2022Q4	BONZ	Preferred Stock Shares Undesignated PreferredStockSharesUndesignated	18999999	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1970000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1970000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1942681876	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1942681876	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1867681876	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1867681876	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	194268	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	194268	usd
CY2023Q1	BONZ	Common Stock To Be Issued Shares CommonStockToBeIssuedShares	140794298026	shares
CY2022Q4	BONZ	Common Stock To Be Issued Shares CommonStockToBeIssuedShares	138468716631	shares
CY2023Q1	BONZ	Common Stock To Be Issued CommonStockToBeIssued	14079430	usd
CY2022Q4	BONZ	Common Stock To Be Issued CommonStockToBeIssued	14079430	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9936191	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	9936191	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2206	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5043	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26722024	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26205029	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-2513303	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1999145	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5041332	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4824774	usd
CY2023Q1	us-gaap	Revenues Revenues	1699698	usd
CY2022Q1	us-gaap	Revenues Revenues	107770	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1402117	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	37780	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	297581	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	69990	usd
CY2023Q1	us-gaap	Development Costs DevelopmentCosts	134129	usd
CY2022Q1	us-gaap	Development Costs DevelopmentCosts	505930	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	190649	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	66866	usd
CY2023Q1	us-gaap	Business Development BusinessDevelopment	45000	usd
CY2022Q1	us-gaap	Business Development BusinessDevelopment	60000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	0	usd
CY2022Q1	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-1246	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	445061	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	444004	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	814839	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1078046	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-517258	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1008056	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-21911	usd
CY2023Q1	BONZ	Sundry Income SundryIncome	263	usd
CY2022Q1	BONZ	Sundry Income SundryIncome	0	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	263	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21911	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-516995	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1029967	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-516995	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1029967	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2837	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	559	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-514158	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1029408	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1942681876	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1867681876	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142736979902	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140336398507	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1999145	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2837	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-516995	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-2513303	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2122683	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	559	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1029967	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3152091	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-516995	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1029967	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12556	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12380	usd
CY2023Q1	BONZ	Revenue Received By Digital Assets RevenueReceivedByDigitalAssets	1647500	usd
CY2022Q1	BONZ	Revenue Received By Digital Assets RevenueReceivedByDigitalAssets	82945	usd
CY2023Q1	BONZ	Expense Settled By Digital Assets ExpenseSettledByDigitalAssets	1647672	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1246	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-0	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-21911	usd
CY2023Q1	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	-0	usd
CY2022Q1	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	-72511	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1387500	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-0	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1649704	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4252	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	33001	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	55441	usd
CY2023Q1	BONZ	Accrued Consulting And Service Fee AccruedConsultingAndServiceFee	621060	usd
CY2022Q1	BONZ	Accrued Consulting And Service Fee AccruedConsultingAndServiceFee	850000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-112410	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-103675	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1890	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1890	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	60000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	usd
CY2023Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	17307	usd
CY2022Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	138785	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	77307	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138785	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	754	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	49	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-34349	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	33269	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99274	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28124	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	64925	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61393	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_841_eus-gaap--UseOfEstimates_zuLyCKA495Rc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span id="xdx_86A_zAU5mcCCVrM4">Use of estimates and assumptions</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates. If actual results significantly differ from the Company’s estimates, the Company’s financial condition and results of operations could be materially impacted. Significant estimates in the period include the impairment loss on digital assets, valuation and useful lives of intangible assets and deferred tax valuation allowance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	BONZ	Capitalize Development Costs CapitalizeDevelopmentCosts	0	usd
CY2022Q1	BONZ	Capitalize Development Costs CapitalizeDevelopmentCosts	0	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	516995	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26722024	usd
CY2023Q1	us-gaap	Revenues Revenues	1699698	usd
CY2022Q1	us-gaap	Revenues Revenues	107770	usd
CY2023Q1	us-gaap	Revenues Revenues	1699698	usd
CY2022Q1	us-gaap	Revenues Revenues	107770	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	157620	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	156502	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-75365	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-62297	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82255	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	94205	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	50328	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	25638	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	948	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	948	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	948	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	3445	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	82255	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12556	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12380	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4707875	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3057342	usd
CY2023Q1	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	621302	usd
CY2023Q1	BONZ	Amounts Due To Related Parties AmountsDueToRelatedParties	1560643	usd
CY2022Q4	BONZ	Amounts Due To Related Parties AmountsDueToRelatedParties	1544729	usd
CY2023Q1	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	30000000	shares
CY2022Q4	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	30000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1970000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1970000000	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1942681876	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1942681876	shares
CY2023Q1	BONZ	Common Stock Committed To Be Issued CommonStockCommittedToBeIssued	140794298026	shares
CY2022Q4	BONZ	Common Stock Committed To Be Issued CommonStockCommittedToBeIssued	140794298026	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-516995	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1029967	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1942681876	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1867681876	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142736979902	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140336398507	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q1	BONZ	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	1942681876	shares
CY2022Q1	BONZ	Weighted Average Common Shares Outstanding Basic And Diluted WeightedAverageCommonSharesOutstandingBasicAndDiluted	1867681876	shares
CY2023Q1	BONZ	Common Stock Committed But Yet To Be Issued CommonStockCommittedButYetToBeIssued	140794298026	shares
CY2022Q1	BONZ	Common Stock Committed But Yet To Be Issued CommonStockCommittedButYetToBeIssued	138468716631	shares
CY2023Q1	BONZ	Weighted Average Common Shares Outstanding Under Ifconverted Method For Basic And Diluted WeightedAverageCommonSharesOutstandingUnderIfconvertedMethodForBasicAndDiluted	142736979902	shares
CY2022Q1	BONZ	Weighted Average Common Shares Outstanding Under Ifconverted Method For Basic And Diluted WeightedAverageCommonSharesOutstandingUnderIfconvertedMethodForBasicAndDiluted	140336398507	shares
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-516995	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1029967	usd
CY2023Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2022Q1	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-0	usd
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	392348	usd
CY2023Q1	BONZ	Cumulative Net Operating Losses CumulativeNetOperatingLosses	11588831	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1970101	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2183699	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2093063	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2183699	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2093063	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	usd
CY2023Q1	BONZ	Management Service Fee ManagementServiceFee	0	usd
CY2022Q1	BONZ	Management Service Fee ManagementServiceFee	72500	usd
CY2022Q2	us-gaap	Investments Investments	20000000	usd
CY2023Q1	BONZ	Equity Purchase From Investors EquityPurchaseFromInvestors	19823750	usd

Files In Submission

Name	View Source	Status
0001683168-23-003294-index-headers.html	Edgar Link	pending
0001683168-23-003294-index.html	Edgar Link	pending
0001683168-23-003294.txt	Edgar Link	pending
0001683168-23-003294-xbrl.zip	Edgar Link	pending
bonanza_ex21.htm	Edgar Link	pending
bonanza_ex3101.htm	Edgar Link	pending
bonanza_ex3102.htm	Edgar Link	pending
bonanza_ex3201.htm	Edgar Link	pending
bonanza_ex3202.htm	Edgar Link	pending
bonanza_i10q-33123.htm	Edgar Link	pending
bonz-20230331.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
bonz-20230331_cal.xml	Edgar Link	unprocessable
bonz-20230331_def.xml	Edgar Link	unprocessable
bonz-20230331_pre.xml	Edgar Link	unprocessable
bonz-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bonanza_i10q-33123_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MVNC
Marvion Inc. Stock $mvnc

2023 Q2 Form 10-Q Financial Statement

#000168316823003294 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVNC Marvion Inc. Stock $mvnc

2023 Q2 Form 10-Q Financial Statement

#000168316823003294 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVNC
Marvion Inc. Stock $mvnc